That works out to roughly 0.8 stories per week across a 33-day span. The busiest single day carried 3. Coverage clusters in pharma, which accounts for 3 of those 4, with the remainder spread across 1 other category. Admanager is the most frequent co-covered peer, appearing in 1 of the 4 tracked stories.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about AI
That works out to roughly 0.8 stories per week across a 33-day span. The busiest single day carried 3. Coverage clusters in pharma, which accounts for 3 of those 4, with the remainder spread across 1 other category. Admanager is the most frequent co-covered peer, appearing in 1 of the 4 tracked stories. Source depth averages 2 original sources per story, versus 3.3 across the same-window beat baseline. Their average consequence score of 6.3 runs above the beat's 6 for that window. This profile follows 4 Biotech stories mentioning AI across the period from February 19, 2026 to March 23, 2026.
Stories tracked
4
Per week
0.8
Sources per story
2
Computed from the 4 stories linked to this entity, with beat comparisons drawn from all 419 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering AI. Shared-story counts are live from our verified record — not editorial picks.
Cearvol has officially launched Wave, a professional-grade hearing aid that integrates artificial intelligence and a touchscreen interface. This award-winning device aims to improve accessibility and user confidence for millions suffering from hearing loss through real-time environmental adaptation.
SpendRule has secured $2M in seed funding to launch its AI-powered platform designed to provide healthcare systems with real-time visibility into operational expenditures. The startup aims to eliminate 'dark spend' and administrative waste within the fragmented financial ecosystems of modern hospitals.
Merck and Mayo Clinic have entered a multi-year research and development collaboration to leverage artificial intelligence for drug discovery and personalized patient care. The partnership integrates Merck's pharmaceutical expertise with Mayo Clinic's clinical data and AI capabilities to accelerate the development of targeted therapies.
Doceree has unveiled Admanager, an AI-driven platform specifically engineered to empower healthcare publishers in managing their digital advertising ecosystems. The tool aims to streamline HCP targeting and data sovereignty, addressing long-standing inefficiencies in the pharmaceutical marketing supply chain.